Cytokinetics (CYTK) Enterprise Value (2010 - 2026)
Cytokinetics (CYTK) recorded Enterprise Value of $8.05 billion in Q3 2026, up 39.9% from $5.76 billion a year earlier but down 24.6% from the prior quarter.
Powered by 
Analysis
Cytokinetics (CYTK) Enterprise Value (2010 - 2026) Analysis & Trends
On a TTM basis, Cytokinetics' Enterprise Value came in at $5.19 billion as of Sep 30, 2026, up 79.9% year-over-year; for FY2025, it came in at $6.93 billion, up 54.5% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of 46.9% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $4.48 billion in FY2024 (-43.0%), $7.87 billion in FY2023 (+121.0%), $3.56 billion in FY2022 (+4.9%) and $3.39 billion in FY2021 (+235.4%).
- Quarterly Enterprise Value has ranged from $2.29 billion in Q3 2023 to $10.68 billion in Q2 2026 over the past five years.
- On a year-over-year basis, Enterprise Value has increased for five consecutive quarters, with growth averaging 39.2% over the last eight quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 245.1% in Q2 2026, against a decline of 43.0% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $10.68 billion (Q2 2026), $7.38 billion (Q1 2026) and $6.93 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Cytokinetics | 7.81 Bn | 3.81 Bn | 47.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 8.05 Bn |
| Jun 30, 2026 | 10.68 Bn |
| Mar 31, 2026 | 7.38 Bn |
| Dec 31, 2025 | 6.93 Bn |
| Sep 30, 2025 | 5.76 Bn |
| Jun 30, 2025 | 3.09 Bn |
| Mar 31, 2025 | 3.86 Bn |
| Dec 31, 2024 | 4.48 Bn |
| Sep 30, 2024 | 5.22 Bn |
| Jun 30, 2024 | 5.32 Bn |
| Mar 31, 2024 | 6.73 Bn |
| Dec 31, 2023 | 7.87 Bn |
| Sep 30, 2023 | 2.29 Bn |
| Jun 30, 2023 | 2.57 Bn |
| Mar 31, 2023 | 2.70 Bn |
| Dec 31, 2022 | 3.56 Bn |
| Sep 30, 2022 | 3.72 Bn |
| Jun 30, 2022 | 3.11 Bn |
| Mar 31, 2022 | 2.54 Bn |
| Dec 31, 2021 | 3.39 Bn |
API Access
Cytokinetics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();